Press Release
Feb 02, 2021
Read our latest press releases, learn about new products, for media inquiries contact media@precision-nano.com
Press Release
Feb 02, 2021
Press Release
Oct 22, 2020
Press Release
Jul 07, 2020
Press Release
Jun 17, 2020
Press Release
May 20, 2020
CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology. Precision NanoSystems will lead RNA vaccine formulation development. CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials
Read More
Press Release
May 07, 2020
Press Release
Apr 14, 2020
Precision NanoSystems (PNI), a global leader in enabling transformative nanomedicines today announced the appointment of Dr. Andrew Geall as the company’s Chief Scientific Officer (CSO). Dr. Geall has over 20 years’ experience in the development of drug deliv...
News Article
Mar 16, 2020
News Article
Jul 30, 2018
Precision Nanosystems' Nanoassemblr technology uses microfluid continuous flow to control variables in the assembly of the nanoparticles. The company has three machines available that can scale depending on which stage of discovery a compound is in...
News Article
Apr 20, 2018
Two Vancouver-based companies are creating industry leading research tools and technology and helping B.C. stake its claim as a world-class burgeoning biotech hub. Precision NanoSystems Inc. (PNI) and Stemcell Technologies Inc. are just two of a gr...
News Article
Dec 20, 2017
Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journalBusiness in Vancouver&nbs...
News Article
Nov 23, 2017
Join Precision NanoSystems for a roundtable discussion on nanomedicines as part of the 3rd International Electronic Conference on Medicinal Chemistry. Organised by Pharmaceuticals journal, this free online conference runs until November 30th, and d...
News Article
Oct 20, 2017
The commercial availability of microfluidic platforms aimed specifically at drug formulation is helping to lower the barriers to nanomedicine research. Implementation of this technology eliminates the need for in-house microfluidics expertise and e...